immune thrombocytopenia (itp)

Showing 1 - 11 of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Immune Thrombocytopenia (ITP) Trial in Germany (Eltrombopag, Dexamethasone)

Recruiting
  • Immune Thrombocytopenia (ITP)
  • Mannheim, Baden-Wuerttemberg, Germany
  • +24 more
Dec 19, 2022

Immune Thrombocytopenia (ITP), Cold Agglutinin Disease (CAD) Trial in Worldwide (Iptacopan)

Recruiting
  • Immune Thrombocytopenia (ITP)
  • Cold Agglutinin Disease (CAD)
  • Boston, Massachusetts
  • +11 more
Dec 15, 2022

Immune Thrombocytopenia (ITP) Trial in Worldwide (BIVV020)

Active, not recruiting
  • Immune Thrombocytopenia (ITP)
  • Washington, District of Columbia
  • +8 more
May 3, 2022

Immune Thrombocytopenia (ITP) Trial (Neofordex®, Intravenous immunoglobulins)

Not yet recruiting
  • Immune Thrombocytopenia (ITP)
  • (no location specified)
Nov 22, 2021

Immune Thrombocytopenia (ITP) Trial (HMPL-523, Placebo)

Not yet recruiting
  • Immune Thrombocytopenia (ITP)
  • (no location specified)
Aug 25, 2021

Immune Thrombocytopenia (ITP), Systemic Lupus Erythematosus (SLE) Trial in Créteil, Paris (Bliss-Believe)

Unknown status
  • Immune Thrombocytopenia (ITP)
  • Systemic Lupus Erythematosus (SLE)
  • Bliss-Believe
  • Créteil, France
  • +1 more
May 21, 2021

Immune Thrombocytopenia (ITP) Trial in United States (Placebo, Lusutrombopag)

Terminated
  • Immune Thrombocytopenia (ITP)
  • Anaheim, California
  • +18 more
Feb 25, 2021

Immune Thrombocytopenia (ITP) Trial in Tianjin (HMPL-523, Placebo)

Unknown status
  • Immune Thrombocytopenia (ITP)
  • Tianjin, Tianjin, China
    Blood diseases hospital, Chinese academy of medical university
Oct 20, 2020

Immune Thrombocytopenia (ITP) Trial in China (Romiplostim)

Completed
  • Immune Thrombocytopenia (ITP)
  • Beijing, China
  • +4 more
Oct 11, 2017

Autoantibody Specificity and Response to IVIG in ITP

Completed
  • Immune Thrombocytopenia (ITP)
    • Jinan, Shandong, China
      Qilu Hospital, Shandong University
    Apr 18, 2016

    Immune Thrombocytopenia (ITP) Trial in Fredrikstad and Oslo (Rituximab (Mabthera))

    Completed
    • Immune Thrombocytopenia (ITP)
    • Rituximab (Mabthera)
    • Fredrikstad and Oslo, Norway
      Østfold Hospital Trust in Fredrikstad and National hospital in O
    Mar 25, 2014